This analysis uncovers predictors of medication adherence in a population, suggesting ways to enhance public health strategies.
Thus, IMAS represents a person-level metric that captures baseline medication-taking behaviour across therapeutic classes and predicts both medication adherence as well as health outcomes. Our analysis suggests that medication-taking behaviour represents a broader patient-level phenomenon manifesting consistently across medications, suggesting its potential for personalised interventions in clinical practice and more efficient public health strategies and policies.
No takes yet. Share an insight, caveat, or question.
Mooses et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: